Novo Nordisk· @novonordisk · X·· 1 天前AI 评分22
AI 导读
#PRESS：对于2型糖尿病患者，心脏健康是诊疗的重要一环。在一项真实世界研究中，换用另一种药物的患者发生严重心脏事件的相对风险，比增加现有药物剂量的患者高6%。 在EASD 2026上公布的完整详情见我们的新闻稿：https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=917053
正文
#PRESS: For people living with type 2 diabetes, heart health is an important part of care. In a real-world study, those who switched to another medicine had a 6% higher relative risk of serious heart events than those who increased the dose of their existing medicine.
Get all the details presented at EASD 2026 in our press release here: https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=917053
来源：Novo Nordisk · x.com